INVASIVE EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI DISEASE (IED) PREVENTION
Clinical trials for INVASIVE EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI DISEASE (IED) PREVENTION explained in plain language.
Never miss a new study
Get alerted when new INVASIVE EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI DISEASE (IED) PREVENTION trials appear
Sign up with your email to follow new studies for INVASIVE EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI DISEASE (IED) PREVENTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine aims to shield seniors from deadly e. coli blood infections
⭐️ VACCINE ⭐️ CompletedThis study tested a vaccine called ExPEC9V to see if it can prevent severe E. coli infections in adults aged 60 and older who had a urinary tract infection in the past 2 years. The vaccine targets nine common types of E. coli that can cause dangerous infections outside the gut, s…
Matched conditions: INVASIVE EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI DISEASE (IED) PREVENTION
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 11:08 UTC
-
New combo vaccine study aims to shield seniors from e. coli and flu
Prevention CompletedThis study tested whether a new vaccine against a serious E. coli infection (ExPEC9V) can be given at the same time as a high-dose flu shot in adults aged 65 and older. The goal was to make sure the immune response to both vaccines stays strong when given together. About 959 heal…
Matched conditions: INVASIVE EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI DISEASE (IED) PREVENTION
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Prevention
Last updated May 26, 2026 12:02 UTC